Survival Outcomes Associated with Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer

Francis I. Macedo, Emily Ryon, Shishir K. Maithel, Rachel M. Lee, David A. Kooby, Ryan C. Fields, William G. Hawkins, Greg Williams, Ugwuji Maduekwe, Hong J. Kim, Syed A. Ahmad, Sameer H. Patel, Daniel E. Abbott, Patrick Schwartz, Sharon M. Weber, Charles R. Scoggins, Robert C.G. Martin, Vikas Dudeja, Dido Franceschi, Alan S. LivingstoneNipun B. Merchant

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'Survival Outcomes Associated with Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences